The European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery: third report
Theo M M H de By(Unknown), Bart Meyns(KU Leuven), Marc Vanderheyden(Onze Lieve Vrouwziekenhuis Hospital), Attilio Iacovoni(Ospedale Papa Giovanni XXIII), Thierry Carrel(IRCCS Ospedale San Raffaele), Jan Gummert(Heart and Diabetes Center North Rhine-Westphalia), David Reineke(University Hospital of Bern), Evgenij Potapov(Deutsches Herzzentrum der Charité), Faiz Ramjankhan(Utrecht University), Antonio Loforte(Department of Medical Sciences), Kyriakos Anastasiadis(AHEPA University Hospital), Arnt E. Fiane(Oslo University Hospital), Daniel Zimpfer(Medical University of Vienna), Alexander Berhnardt(Centrum kardiovaskulární a transplantační chirurgie), Gregorio Rábago(Sorbonne Université), Diyar Saeed(Helios Klinikum Krefeld), Francesco Musumeci(IRCCS San Camillo Hospital), Bernard Stockman(Onze Lieve Vrouwziekenhuis Hospital), Kevin M. Veen(Erasmus MC), Yuriy Pya, Julia Stein(Charité - Universitätsmedizin Berlin), Can Gollmann‐Tepeköylü(Innsbruck Medical University), Kevin Damman(University Medical Center Groningen), Felix Schoenrath(Deutsches Herzzentrum der Charité), Mustafa Özbaran(Ege University), Ivan Netuka(Institute of Clinical and Experimental Medicine), M. Zembala(Silesian Center for Heart Disease), Hermann Reichenspurner(Universität Hamburg), Thorsten Wahlers(Centrum für Integrierte Onkologie), Aggeliki Gkouziouta(Onassis Cardiac Surgery Center), Laurens F. Tops(Leiden University Medical Center), Friedhelm Beyersdorf(University of Freiburg), Béla Merkely(Semmelweis University), Michal Hulman(National Institute of Cardiovascular Diseases), Paul Mohaçsi(Medical University of Graz), Petr Němec(Charles University), Khalid Alkhamees(Prince Sultan University), Elena Sandoval, Kadir Çalişkan(Erasmus MC)
Cited by 58
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
Guidelines on the management of valvular heart disease (version 2012)
|European Journal of Cardio-Thoracic Surgery|2012|2k